Extracellular vesicle profiling and their use as potential disease specific biomarker

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Julich, Henrike ^a   Willms, Arnulf ^b   Lukacs Kornek, Veronika ^a   Kornek, Miroslaw ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

Author keywords

Extracellular vesicles; Microparticles; Microvesicles; miRNA; Profiling

Indexed keywords

BIOLOGICAL MARKER; CD 42 ANTIGEN; CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ENDOGLIN; EPITHELIAL CELL ADHESION MOLECULE; FAS ANTIGEN; FIBRINOGEN RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; MICRORNA; UNCLASSIFIED DRUG; BETA3 INTEGRIN; CD19 ANTIGEN; CD51 ANTIGEN; LIPOCORTIN 5; MESSENGER RNA; PADGEM PROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER SCREENING; CELL MEMBRANE; EXTRACELLULAR VESICLE; FLUORESCENCE ACTIVATED CELL SORTING; HEPATITIS B; LIVER CELL CARCINOMA; RADIOGRAPHY; TREATMENT OUTCOME; ANGIOGENESIS; APOPTOSIS; ARTHRITIS; ATHEROSCLEROSIS; CELL COMMUNICATION; CELL ORGANELLE; CELL PROLIFERATION; CELL VACUOLE; CYTOMETRY; DERMATOMYOSITIS; DISEASE COURSE; DISEASE MARKER; EXOSOME; GENE EXPRESSION PROFILING; HEPATITIS C; HISTOLOGY; HUMAN; MALARIA; MENINGOCOCCEMIA; NEOPLASM; NONALCOHOLIC FATTY LIVER; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; TUMOR INVASION;

EID: 84919394606     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00413     Document Type: Article

References (60)

1. Abrahams, V.M., Straszewski-Chavez, S.L, Guller, S., and Mor, G. (2004). First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 10, 55-63.
2. Akers, J.C., Gonda, D., Kim, R., Carter, B.S., and Chen, C.C. (2013). Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol 113, 1-11.
3. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L, Guha, A., and Rak, J. (2008). Intercellular transfer of the oncogenic receptor EGFRvlll by microvesicles derived from tumour cells. Nat Cell Biol 10, 619-624.
4. Alix-Panabieres, C, and Pantel, K. (2013). Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59, 110- 118.
5. Atay, S., Banskota, S., Crow, J., Sethi, G., Rink, L, and Godwin, A.K. (2014). Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc Natl Acad Sci USA 111, 711- 716.
6. Baka, Z., Senolt, L, Vencovsky, J., Mann, H., Simon, P.S., Kittel, A., Buzas, E., and Nagy, G. (2010). Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunol Lett 128, 124-130.
7. Baran, J., Baj-Krzyworzeka, M., Weglarczyk, K., Szatanek, R., Zembala, M., Barbasz, J., Czupryna, A., Szczepanik, A., and Zembala, M. (2010). Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 59, 841-850.
8. Benameur, T., Soleti, R., Porro, C, Andriantsitohaina, R., and Martinez, M.C. (2010). Microparticles carrying Sonic hedgehog favor neovascularization through the activation of nitric oxide pathway in mice. PLoS OneS, el2688.
9. Beyer, C, and Pisetsky, D.S. (2010). The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 6, 21-29.
10. Boilard, E., Nigrovic, P.A., Larabee, K., Watts, G.F., Coblyn, J.S., Weinblatt, M.E., Massarotti, E.M., Remold- O'donnell, E., Farndale, R.W., Ware, J., and Lee, D.M. (2010). Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327, 580-583.
11. Brodsky, S.V., Facciuto, M.E., Heydt, D., Chen, J., Islam, H.K., Kajstura, M., Ramaswamy, G., and Aguero- Rosenfeld, M. (2008). Dynamics of circulating microparticles in liver transplant patients. J Gastrointestin Liver Dis 17, 261-268.
12. Canault, M., Leroyer, A.S., Peiretti, F., Leseche, G., Tedgui, A., Bonardo, B., Alessi, M.C., Boulanger, CM., and Nalbone, G. (2007). Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol 111, 1713-1723.
13. Castellana, D., Zobairi, F., Martinez, M.C., Panaro, M.A., Mitolo, V., Freyssinet, J.M., and Kunzelmann, C. (2009). Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 69, 785-793.
14. Chen, X., Liang, H., Zhang, J., Zen, K., and Zhang, C.Y. (2012). Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 3, 28-37.
15. D'souza-Schorey, C, and Clancy, J.W. (2012). Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 26, 1287-1299.
16. Diehl, P., Fricke, A., Sander, L, Stamm, J., Bassler, N., Htun, N., Ziemann, M., Helbing, T., El-Osta, A., Jowett, J.B., and Peter, K. (2012). Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 93, 633-644.
17. Distler, J.H., Huber, L.C., Hueber, A.J., Reich, C.F., 3rd, Gay, S., Distler, O., and Pisetsky, D.S. (2005). The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis 10, 731-741.
18. Fleitas, T., Martinez-Sales, V., Vila, V., Reganon, E., Mesado, D., Martin, M., Gomez-Codina, J., Montalar, J., and Reynes, G. (2012). Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS One 7, e47365.
19. Frey, B., and Gaipl, U.S. (2011). The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol 33, 497-516.
20. Fritzsching, B., Schwer, B., Kartenbeck, J., Pedal, A., Horejsi, V., and Ott, M. (2002). Release and intercellular transfer of cell surface CD81 via microparticles. J Immunol 169, 5531-5537.
21. Gieseler, F., Gamperl, H., Theophil, F., Stenzel, I., Quecke, T., Ungefroren, H., and Lehnert, H. (2014). Using annexin V-coated magnetic beads to capture active tissue factor-bearing microparticles from body fluids. Cell Biol Int 38, 277-281.
22. Gyorgy, B., Szabo, T.G., Pasztoi, M., Pal, Z., Misjak, P., Aradi, B., Laszlo, V., Pallinger, E., Pap, E., Kittel, A., Nagy, G., Falus, A., and Buzas, E.I. (2011). Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68, 2667-2688.
23. He, W.A., Calore, F., Londhe, P., Canella, A., Guttridge, D.C., and Croce, CM. (2014). Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci USA 111, 4525-4529.
24. Hessvik, N.P., Sandvig, K., and Llorente, A. (2013). Exosomal miRNAs as Biomarkers for Prostate Cancer. Front Genet 4, 36.
25. Hong, B.S., Cho, J.H., Kim, H., Choi, E.J., Rho, S., Kim, J., Kim, J.H., Choi, D.S., Kim, Y.K., Hwang, D., and Gho, Y.S. (2009). Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMCGenomics 10, 556.
26. Hunter, M.P., Ismail, N., Zhang, X., Aguda, B.D., Lee, E.J., Yu, L., Xiao, T., Schafer, J., Lee, M.L., Schmittgen, T.D., Nana-Sinkam, S.P., Jarjoura, D., and Marsh, C.B. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694.
27. Itakura Sumi, Y., Ogura, H., Tanaka, H., Koh, T., Fujita, K., Fujimi, S., Nakamori, Y., Shimazu, T., and Sugimoto, H. (2003). Paradoxical cytoskeleton and microparticle formation changes in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients. J Trauma 55, 1125-1132.
28. Kim, J.W., Wieckowski, E., Taylor, D.D., Reichert, T.E., Watkins, S., and Whiteside, T.L (2005). Fas ligandpositive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11, 1010-1020.
29. Konigsberg, R., Gneist, M., Jahn-Kuch, D., Pfeiler, G., Hager, G., Hudec, M., Dittrich, C, and Zeillinger, R. (2010). Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Lett 293, 117-123.
30. Kornek, M., Lynch, M., Mehta, S.H., Lai, M., Exley, M., Afdhal, N.H., and Schuppan, D. (2012). Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143, 448-458.
31. Kornek, M., Popov, Y., Libermann, T.A., Afdhal, N.H., and Schuppan, D. (2011). Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 53, 230-242.
32. Kornek, M., and Schuppan, D. (2012). Microparticles: Modulators and biomarkers of liver disease. J Hepatol 57, 1144-1146.
33. Li, L., Masica, D., Ishida, M., Tomuleasa, C, Umegaki, S., Kalloo, A.N., Georgiades, C, Singh, V.K., Khashab, M., Amateau, S., Li, Z., Okolo, P., Lennon, A.M., Saxena, P., Geschwind, J.F., Schlachter, T., Hong, K., Pawlik, T.M., Canto, M., Law, J., Sharaiha, R., Weiss, C.R., Thuluvath, P., Goggins, M., Shin, E.J., Peng, H., Kumbhari, V., Hutfless, S., Zhou, L, Mezey, E., Meltzer, S.J., Karchin, R., and Selaru, F.M. (2014). Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology.
34. Martins, V.R., Dias, M.S., and Hainaut, P. (2013). Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 25, 66-75.
35. Mego, M., Mani, S.A., and Cristofanilli, M. (2010). Molecular mechanisms of metastasis in breast cancerclinical applications. Nat Rev Clin Oncol 7, 693-701.
36. Munster, M., Fremder, E., Miller, V., Ben-Tsedek, N., Davidi, S., Scherer, S.J., and Shaked, Y. (2014). Anti- VEGF-A Affects the Angiogenic Properties of Tumor-Derived Microparticles. PLoS One 9, e95983.
37. Nieuwland, R., Berckmans, R.J., Mcgregor, S., Boing, A.N., Romijn, F.P., Westendorp, R.G., Hack, C.E., and Sturk, A. (2000). Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95, 930-935.
38. Nozaki, T., Sugiyama, S., Sugamura, K., Ohba, K., Matsuzawa, Y., Konishi, M., Matsubara, J., Akiyama, E., Sumida, H., Matsui, K., Jinnouchi, H., and Ogawa, H. (2010). Prognostic value of endothelial microparticles in patients with heart failure. EurJ Heart Fail 12, 1223-1228.
39. Ogura, H., Kawasaki, T., Tanaka, H., Koh, T., Tanaka, R., Ozeki, Y., Hosotsubo, H., Kuwagata, Y., Shimazu, T., and Sugimoto, H. (2001). Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 50, 801-809.
40. Pankoui Mfonkeu, J.B., Gouado, I., Fotso Kuate, H., Zambou, O., Amvam Zollo, P.H., Grau, G.E., and Combes, V. (2010). Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5, el3415.
41. Paterlini-Brechot, P., and Benali, N.L. (2007). Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253, 180-204.
42. Periard, D., Boulanger, CM., Eyer, S., Amabile, N., Pugin, P., Gerschheimer, C, and Hayoz, D. (2007). Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke 38, 1636-1638.
43. Riethdorf, S., Fritsche, H., Muller, V., Rau, T., Schindlbeck, C, Rack, B., Janni, W., Coith, C, Beck, K., Janicke, F., Jackson, S., Gornet, T., Cristofanilli, M., and Pantel, K. (2007). Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 13, 920-928.
44. Rozmyslowicz, T., Majka, M., Kijowski, J., Murphy, S.L., Conover, D.O., Poncz, M., Ratajczak, J., Gaulton, G.N., and Ratajczak, M.Z. (2003). Platelet-and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 17, 33-42.
45. Schmelzle, M., Splith, K., Andersen, L.W., Kornek, M., Schuppan, D., Jones-Bamman, C, Nowak, M., Toxavidis, V., Salhanick, S.D., Han, L, Schulte Am Esch, J., Jonas, S., Donnino, M.W., and Robson, S.C. (2013). Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation 95, 63-69.
46. Schulze, K., Gasch, C, Staufer, K., Nashan, B., Lohse, A.W., Pantel, K., Riethdorf, S., and Wege, H. (2013). Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. IntJ Cancer 133, 2165-2171.
47. Shao, H., Chung, J., Balaj, L, Charest, A., Bigner, D.D., Carter, B.S., Hochberg, F.H., Breakefield, X.O., Weissleder, R., and Lee, H. (2012). Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 18, 1835-1840.
48. Sims, P.J., Faioni, E.M., Wiedmer, T., and Shattil, S.J. (1988). Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263, 18205-18212.
49. Sinning, J.M., Losch, J., Walenta, K., Bohm, M., Nickenig, G., and Werner, N. (2011). Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 32, 2034-2041.
50. Sun, L, Hu, J., Xiong, W., Chen, X., Li, H., and Jie, S. (2013a). MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma. Acta Gastroenterol Belg 76, 386-392.
51. Sun, Y.F., Xu, Y., Yang, X.R., Guo, W., Zhang, X., Qiu, S.J., Shi, R.Y., Hu, B., Zhou, J., and Fan, J. (2013b). Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57, 1458-1468.
52. Thery, C, Ostrowski, M., and Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9, 581-593.
53. Thery, C, Zitvogel, L., and Amigorena, S. (2002). Exosomes: composition, biogenesis and function. Nat Rev Immunol 2, 569-579.
54. Thomas, G.M., Panicot-Dubois, L., Lacroix, R., Dignat-George, F., Lombardo, D., and Dubois, C. (2009). Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 206, 1913-1927.
55. Tseng, J.C., Chang, L.C., Jiang, B.Y., Liu, Y.C., Chen, H.J., Yu, C.T., and Hua, C.C. (2014). Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer. J Cancer Res Clin Oncol 140, 61-67.
56. Turchinovich, A., Samatov, T.R., Tonevitsky, A.G., and Burwinkel, B. (2013). Circulating miRNAs: cell-cell communication function? Front Genet 4, 119.
57. Wang, W., Li, H., Zhou, Y., and Jie, S. (2013). Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma. Cancer Biomark 13, 351-357.
58. Wolf, P. (1967). The nature and significance of platelet products in human plasma. BrJ Haematol 13, 269- 288.
59. Yoshioka, Y., Konishi, Y., Kosaka, N., Katsuda, T., Kato, T., and Ochiya, T. (2013). Comparative marker analysis of extracellular vesicles in different human cancer types. J Extracell Vesicles 2.
60. Zhuang, G., Wu, X., Jiang, Z., Kasman, I., Yao, J., Guan, Y., Oeh, J., Modrusan, Z., Bais, C, Sampath, D., and Ferrara, N. (2012). Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 31, 3513-3523.